99 related articles for article (PubMed ID: 9098683)
1. Tachykinin NK1 receptor antagonist RP67580 attenuates progressive hypersensitivity of flexor reflex during experimental inflammation in rats.
Ma QP; Woolf CJ
Eur J Pharmacol; 1997 Mar; 322(2-3):165-71. PubMed ID: 9098683
[TBL] [Abstract][Full Text] [Related]
2. Morphine, the NMDA receptor antagonist MK801 and the tachykinin NK1 receptor antagonist RP67580 attenuate the development of inflammation-induced progressive tactile hypersensitivity.
Ma QP; Allchorne AJ; Woolf CJ
Pain; 1998 Jul; 77(1):49-57. PubMed ID: 9755018
[TBL] [Abstract][Full Text] [Related]
3. Spinal NK1 receptors contribute to the increased excitability of the nociceptive flexor reflex during persistent peripheral inflammation.
Parsons AM; Honda CN; Jia YP; Budai D; Xu XJ; Wiesenfeld-Hallin Z; Seybold VS
Brain Res; 1996 Nov; 739(1-2):263-75. PubMed ID: 8955947
[TBL] [Abstract][Full Text] [Related]
4. The tachykinin NK1 receptor antagonist, RP67580, inhibits the bradykinin-induced rise in intracellular Ca2+ concentration in bovine pulmonary artery endothelial cells.
Westra-De Vlieger JF; Van Den Wijngaard PW; Koster AS; Wilting J; Leysen J; Van Heuven-Nolsen D; Nijkamp FP
Eur J Pharmacol; 1998 Jan; 342(2-3):359-66. PubMed ID: 9548409
[TBL] [Abstract][Full Text] [Related]
5. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-Fos expression.
Chapman V; Buritova J; Honoré P; Besson JM
J Neurophysiol; 1996 Sep; 76(3):1817-27. PubMed ID: 8890294
[TBL] [Abstract][Full Text] [Related]
6. Effect of RP 67580, a non-peptide neurokinin1 receptor antagonist, on facilitation of a nociceptive spinal flexion reflex in the rat.
Laird JM; Hargreaves RJ; Hill RG
Br J Pharmacol; 1993 Jul; 109(3):713-8. PubMed ID: 8395296
[TBL] [Abstract][Full Text] [Related]
7. Involvement of neurokinin receptors in the induction but not the maintenance of mechanical allodynia in rat flexor motoneurones.
Ma QP; Woolf CJ
J Physiol; 1995 Aug; 486 ( Pt 3)(Pt 3):769-77. PubMed ID: 7473237
[TBL] [Abstract][Full Text] [Related]
8. Progressive tactile hypersensitivity: an inflammation-induced incremental increase in the excitability of the spinal cord.
Ma QP; Woolf CJ
Pain; 1996 Sep; 67(1):97-106. PubMed ID: 8895236
[TBL] [Abstract][Full Text] [Related]
9. Central versus peripheral site of action of the tachykinin NK1-antagonist RP 67580 in inhibiting chemonociception.
Holzer-Petsche U; Rordorf-Nikolić T
Br J Pharmacol; 1995 Jun; 115(3):486-90. PubMed ID: 7582461
[TBL] [Abstract][Full Text] [Related]
10. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
11. Spinal delta-opioid receptors mediate suppression of systemic SNC80 on excitability of the flexor reflex in normal and inflamed rat.
Cao CQ; Hong Y; Dray A; Perkins M
Eur J Pharmacol; 2001 Apr; 418(1-2):79-87. PubMed ID: 11334868
[TBL] [Abstract][Full Text] [Related]
12. Effect of tachykinin receptor antagonists in experimental neuropathic pain.
Coudoré-Civiale MA; Courteix C; Eschalier A; Fialip J
Eur J Pharmacol; 1998 Nov; 361(2-3):175-84. PubMed ID: 9865506
[TBL] [Abstract][Full Text] [Related]
13. Effects of RP 67580, a tachykinin NK1 receptor antagonist, on a primary afferent-evoked response of ventral roots in the neonatal rat spinal cord.
Hosoki R; Yanagisawa M; Guo JZ; Yoshioka K; Maehara T; Otsuka M
Br J Pharmacol; 1994 Dec; 113(4):1141-6. PubMed ID: 7534180
[TBL] [Abstract][Full Text] [Related]
14. Involvement of spinal tachykinin NK1 and NK2 receptors in detrusor hyperreflexia during chemical cystitis in anaesthetized rats.
Lecci A; Giuliani S; Santicioli P; Maggi CA
Eur J Pharmacol; 1994 Jul; 259(2):129-35. PubMed ID: 7957606
[TBL] [Abstract][Full Text] [Related]
15. Temperature and agonist dependency of tachykinin NK1 receptor antagonist potencies in rat isolated superior cervical ganglion.
Hawcock AB; Beresford IJ; Marshall FH; Hagan RM
Eur J Pharmacol; 1995 Dec; 294(1):163-71. PubMed ID: 8788428
[TBL] [Abstract][Full Text] [Related]
16. A non-peptide NK1-receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynaptically.
Moussaoui SM; Montier F; Carruette A; Blanchard JC; Laduron PM; Garret C
Br J Pharmacol; 1993 May; 109(1):259-64. PubMed ID: 7684305
[TBL] [Abstract][Full Text] [Related]
17. Evidence for an involvement of tachykinins in allodynia in streptozocin-induced diabetic rats.
Coudoré-Civiale M; Courteix C; Boucher M; Fialip J; Eschalier A
Eur J Pharmacol; 2000 Jul; 401(1):47-53. PubMed ID: 10915836
[TBL] [Abstract][Full Text] [Related]
18. RP67580, a neurokinin1 receptor antagonist, decreased restraint stress-induced defecation in rat.
Ikeda K; Miyata K; Orita A; Kubota H; Yamada T; Tomioka K
Neurosci Lett; 1995 Sep; 198(2):103-6. PubMed ID: 8592631
[TBL] [Abstract][Full Text] [Related]
19. Nerve growth factor induces mechanical allodynia associated with novel A fibre-evoked spinal reflex activity and enhanced neurokinin-1 receptor activation in the rat.
Thompson SWN; Dray A; McCarson KE; Krause JE; Urban L
Pain; 1995 Aug; 62(2):219-231. PubMed ID: 8545148
[TBL] [Abstract][Full Text] [Related]
20. RP-67580, a specific tachykinin NK1 receptor antagonist, relieves chronic hyperalgesia in diabetic rats.
Courteix C; Lavarenne J; Eschalier A
Eur J Pharmacol; 1993 Sep; 241(2-3):267-70. PubMed ID: 7694865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
